FindTrial
Sign In

Patient Registry: Radio Frequency Ablation of Barrett's Esophagus Using HALO System

Single Center Patient Registry Using Radio Frequency Ablation of Barrett's Esophagus Using HALO System

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02033070
Acronym
HALO
Enrollment
Unknown
Registered
2014-01-10
Start date
2013-11-30
Completion date
Unknown
Last updated
2014-01-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Barrett's Esophagus

Keywords

RFA

Brief summary

The purpose of this study is to provide a tool for physicians to compare outcome data related to the use of the HALO Ablation Systems. This study is a single-center patient registry which will contribute to a framework for treatment and follow-up of patients with Barrett's Esophagus.

Interventions

None listed

Sponsors

Ochsner Health System
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* candidate for ablation of Barrett's Esophagus with the HALO Ablation System (Prospective) * received an ablation with the HALO Ablation System to treat Barrett's Esophagus (Retrospective) * candidate agrees to proposed follow-up schedule of yearly surveillance following treatment * signs consent

Exclusion criteria

* has not been diagnosed with Barrett's Esophagus

Design outcomes

Primary

MeasureTime frame
Endoscopic clearance rate for Barrett's EsophagusOutcome measure is assessed at Month 12

Secondary

MeasureTime frame
Histological clearance rate for intestinal metaplasiaBiopsy taken at 12 months

Other

MeasureTime frame
Histological clearance rate for dysplasiaBiopsy taken at 12 months to determine effectiveness

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026